Journal of Gastroenterology

Article	Citations
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	316
Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease	247
WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway	176
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	138
A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials	95
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	85
Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis	73
LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	64
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study	56
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	53
Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel	46
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	45
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	43
Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous superficial esophageal squamous cell carcinoma	42
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	38
Utility of a new automated diagnostic program in high-resolution esophageal manometry	37
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation	37
The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis	37
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis	36
Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B	35
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study	32
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells	30
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation	30
The useful predictors of zinc deficiency for the management of chronic liver disease	29
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	26

Renal manifestations in inflammatory bowel disease: a systematic review	26
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	26
Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy	25
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	24
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	24
The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention	24
The first comprehensive genomic characterization of rectal squamous cell carcinoma	24
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development	23
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy	23
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	23
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	22
Further notice of omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation	22
Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis	21
Computer-aided demarcation of early gastric cancer: a pilot comparative study with endoscopists	21
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	21
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance	20
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe	18
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia	18
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia	18
Assessing the side effects and resistance in H. pylori treatment: a discussion on minocycline versus tetracycline therapy	18
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	18
Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	17
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy	17
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	16
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma	16
A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion	16
Response to the letter by Buldukoglu et al. regarding our manuscript “Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-	16
Single-molecule sequencing of the whole HCV genome revealed envelope deletions in decompensated cirrhosis associated with NS2 and NS5A mutations	16
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	16
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	16
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy	16
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis	15
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey	15
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan	15
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia	15
Multistage deep learning for classification of Helicobacter pylori infection status using endoscopic images	15
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation	15
Non-invasive early detection on esophageal squamous cell carcinoma and precancerous lesions by microbial biomarkers combining epidemiological factors in China	14
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma	14
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	14
Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission	14
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation	14
Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity	14
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study	14
Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials	14
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	13
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance	13
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer	13
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization	13
Controversy regarding the risk of autoimmune gastritis on gastric adenocarcinoma	13

Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation	12
Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database	11
MAFLD: an optimal framework for understanding liver cancer phenotypes	11
Prevalence and predictability of the Chicago Classification of Pouchitis in ulcerative colitis: a multicenter study in Japan	11
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts	11
Acknowledgements	11
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY	11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co	11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer	10
Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B	10
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis	10
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	10
The clonal heterogeneity of colon cancer with liver metastases	10
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents	10
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease	10
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	10
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation	10
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer	10
Current status of molecular diagnostic approaches using liquid biopsy	10
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’	10
Acknowledgements	10
Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD	10
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	10
Standard technique in Japan for measuring hepatic venous pressure gradient	10
Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study	10
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT	10
Arginase 2 attenuates ulcerative colitis by antioxidant effects of spermidine	9
Role of combined aerobic and resistance exercise in liver cirrhosis	9
MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents	9
Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients	9
Promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy	9
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease	9
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	9
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases	8
Association of circulating cytokine levels and tissue-infiltrating myeloid cells with achalasia: results from Mendelian randomization and validation through clinical characteristics and single-cell RN	8
Multisample lipidomic profiles of irritable bowel syndrome and irritable bowel syndrome-like symptoms in patients with inflammatory bowel disease: new insight into the recognition of the same symptoms	8
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	8
Small extracellular vesicles derived from adipose mesenchymal stem cells alleviate intestinal fibrosis by inhibiting the FAK/Akt signaling pathway via MFGE8	8
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	8
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses	8
The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma	8
Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study	8
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis	8
Conditional deletion of IP3R1 by Islet1-Cre in mice reveals a critical role of IP3R1 in interstitial cells of Cajal in regulating GI motility	7
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan	7
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma	7
Robust automated prediction of the revised Vienna Classification in colonoscopy using deep learning: development and initial external validation	7
Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives	7
Correction: The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry	7
Immune therapies against chronic hepatitis B	7
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT	7
The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors	7
Correction to: The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis	7
A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis	7
Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?	7
Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease	7
STING and liver disease	7
Multicenter, cross-sectional, observational study on Epstein–Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study)	7
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients	7
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression	7
Clinical features of superficial esophagus squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes	7
Aldh2 and the tumor suppressor Trp53 play important roles in alcohol-induced squamous field cancerization	6
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	6
The association between phosphate level at admission and early mortality in acute pancreatitis	6
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease	6
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	6
Single-cell RNA sequencing and functional analysis reveal the role of altered glycosylation levels of hepatic macrophages in liver cirrhosis	6
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan	6
Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan	6
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	6
Clinical practice guidelines for duodenal cancer 2021	6
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	6
Publisher Correction: Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	6
Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas	6
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver	6
Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults.	6
Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer	6
Acknowledgements	5
Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	5

A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding	5
Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer	5
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021	5
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	5
Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction	5
Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019	5
Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study	5
Evidence-based clinical practice guidelines for chronic pancreatitis 2021	5
Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma	5
Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma	5
Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma	5
Novel probiotic yeast from Miso promotes regulatory dendritic cell IL-10 production and attenuates DSS-induced colitis in mice	5
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	5
Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment	5
Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study	5
Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”	5
Alteration of protein expression and spliceosome pathway activity during Barrett’s carcinogenesis	5
A proposed risk assessment score for gastrointestinal stromal tumors based on evaluation of 19,030 cases from the National Cancer Database	5
Acknowledgements	5
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery	5
Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan	5
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study	5
Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type	5
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study	4
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	4
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer	4
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	4
Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis	4
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey	4
Medical costs according to the stages of colorectal cancer: an analysis of health insurance claims in Hachioji, Japan	4
Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States	4
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma	4
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study	4
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach	4
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum	4
Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin–bil	4
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway	4
Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation	4
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria	4
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study	4
Microinflammation in the intestinal mucosa and symptoms of irritable bowel syndrome	4
Correction to: Features of the gut prokaryotic virome of Japanese patients with Crohn’s disease	4
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan	4
Reply: Need for evidence on surveillance endoscopy in achalasia-related Barret esophagus and adenocarcinoma in Asian population	4
Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020	4
VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization	3
Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn’s disease in Japan (SPREAD-J study)	3
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma	3
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	3
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation	3
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse	3
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan	3
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan	3
High-mobility group box 1: friend or foe in pancreatitis	3
Risk of pneumonia associated with proton pump inhibitor use	3
Gastric intestinal metaplasia: progress and remaining challenges	3
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices	3
Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer scre	3
The antiferroptotic effect of indigo on ulcerative colitis	3
Heparan sulfate acts as an activator of the NLRP3 inflammasome promoting inflammatory response in the development of acute pancreatitis	3
Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern	3
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”	3
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA	3
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study	3
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	3
Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia	3
Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation	3
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan	3
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer	3
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria	3
Impact of mindfulness tendency and physical activity on brain-gut interactions	3
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection	3
Reply to “Severe ulcerative colitis: diagnostic criteria and therapy”	3
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”	3
Cancer risk by length of Barrett’s esophagus in Japanese population: a nationwide multicenter retrospective cohort study	2
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan	2
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	2
COVID-19-associated liver injury (COVALI): role of hepatologists	2
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicen	2
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021	2
Allograft liver failure awaiting liver transplantation in Japan	2
Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis	2
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors	2
Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease	2
Application of polyglycolic acid sheets and basic fibroblast growth factor to prevent esophageal stricture after endoscopic submucosal dissection in pigs	2
Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma	2
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a	2
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma	2
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes	2
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?	2
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort	2
Comparison of a novel mini-oral sulfate tablet and the conventional oral sulfate tablet in bowel preparation for colonoscopy: a prospective, randomized, investigator-blinded, multicenter, non-inferior	2
Acknowledgements	2
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020	2
Current status of type 1 (IgG4-related) autoimmune pancreatitis	2